Quanterix Corporation (NASDAQ:QTRX) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Quanterix Corporation (NASDAQ:QTRX) has received an average rating of "Hold" from five research firms, with four hold recommendations and one buy recommendation, reflecting cautious sentiment among analysts.
• Recent insider activity includes two directors purchasing a significant number of shares, indicating confidence in the company's potential, with a total of 463,113 shares worth $2,625,444 bought in the last quarter.
• The company's stock price has seen volatility, recently trading at $4.49, down 1.3%, and reported earnings that missed consensus estimates with a negative net margin of 56.04%.

Shares of Quanterix Corporation (NASDAQ:QTRX - Get Free Report) have been given an average rating of "Hold" by the five research firms that are covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $11.75.

QTRX has been the topic of several recent research reports. Canaccord Genuity Group restated a "hold" rating and set a $5.00 price target (down previously from $12.00) on shares of Quanterix in a report on Monday, August 11th. Wall Street Zen lowered shares of Quanterix from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd.

Quanterix Trading Up 5.3%

NASDAQ QTRX traded up $0.23 during trading hours on Wednesday, reaching $4.55. The company had a trading volume of 390,973 shares, compared to its average volume of 697,629. The stock has a 50-day moving average of $5.44 and a 200 day moving average of $5.83. Quanterix has a 1-year low of $4.05 and a 1-year high of $15.85. The stock has a market capitalization of $211.44 million, a P/E ratio of -2.50 and a beta of 1.03.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.06). The business had revenue of $24.48 million during the quarter, compared to analyst estimates of $29.73 million. Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. Quanterix has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Quanterix will post -0.98 EPS for the current year.

Insider Buying and Selling at Quanterix

In other news, Director David R. Walt bought 123,990 shares of the business's stock in a transaction that occurred on Friday, June 13th. The shares were purchased at an average cost of $6.14 per share, for a total transaction of $761,298.60. Following the completion of the purchase, the director owned 1,866,933 shares of the company's stock, valued at approximately $11,462,968.62. This represents a 7.11% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have purchased 238,131 shares of company stock worth $1,402,860 in the last 90 days. 6.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Quanterix

A number of large investors have recently made changes to their positions in the company. Ameriprise Financial Inc. increased its stake in shares of Quanterix by 14.0% during the second quarter. Ameriprise Financial Inc. now owns 4,236,877 shares of the company's stock worth $28,175,000 after buying an additional 521,639 shares during the period. Millennium Management LLC increased its stake in Quanterix by 6.0% in the fourth quarter. Millennium Management LLC now owns 2,185,101 shares of the company's stock valued at $23,228,000 after purchasing an additional 122,969 shares during the last quarter. Easterly Investment Partners LLC increased its stake in Quanterix by 38.8% in the first quarter. Easterly Investment Partners LLC now owns 1,325,620 shares of the company's stock valued at $8,630,000 after purchasing an additional 370,625 shares during the last quarter. William Blair Investment Management LLC increased its stake in Quanterix by 2.0% in the second quarter. William Blair Investment Management LLC now owns 1,127,981 shares of the company's stock valued at $7,501,000 after purchasing an additional 21,918 shares during the last quarter. Finally, Blue Water Life Science Advisors LP increased its stake in Quanterix by 157.3% in the second quarter. Blue Water Life Science Advisors LP now owns 957,747 shares of the company's stock valued at $6,369,000 after purchasing an additional 585,572 shares during the last quarter. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.